Latest Articles
Robotic surgery is revolutionizing endometriosis treatment and improving fertility: Experts - Healthcare Radius
Robotic surgery is revolutionizing endometriosis treatment and improving fertility: Experts Healthcare Radius
Published: Feb. 7, 2025, 7:16 a.m.
The Effect of Hysteroscopic Endometrial Polypectomy Combined With LNG-IUS Treatment on Polyp Recurrence: A Multicenter Retrospective Study - Frontiers
The Effect of Hysteroscopic Endometrial Polypectomy Combined With LNG-IUS Treatment on Polyp Recurrence: A Multicenter Retrospective Study Frontiers
Published: Feb. 3, 2025, 2:13 p.m.
Endometrial Cancer Treatment Market: Rapid CAGR, Rising - openPR
Endometrial Cancer Treatment Market: Rapid CAGR, Rising openPR
Published: Jan. 23, 2025, 6:43 p.m.
US Pelvic Health Company Elitone Launches in UK with Non-Invasive Pelvic Floor Treatment Device - Femtech Insider
US Pelvic Health Company Elitone Launches in UK with Non-Invasive Pelvic Floor Treatment Device Femtech Insider
Published: Jan. 23, 2025, 10:54 a.m.
Lab firm BioGrad hoped women's health centre could find treatments for 'neglected' conditions like endometriosis and PCOS - MSN
Lab firm BioGrad hoped women's health centre could find treatments for 'neglected' conditions like endometriosis and PCOS MSN
Published: Jan. 22, 2025, 3:22 a.m.
Lab firm BioGrad hopes women's health centre could find treatments for 'neglected' conditions like endometriosis and PCOS - MSN
Lab firm BioGrad hopes women's health centre could find treatments for 'neglected' conditions like endometriosis and PCOS MSN
Published: Jan. 22, 2025, 2:20 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - EIN News
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR EIN News
Published: Jan. 21, 2025, 10:38 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire
Published: Jan. 21, 2025, 12:38 a.m.
Management of Diaphragmatic Central Tendon Plays an Important Role in the Surgical Treatment of Catamenial Pneumothorax: A Case Report - Cureus
Management of Diaphragmatic Central Tendon Plays an Important Role in the Surgical Treatment of Catamenial Pneumothorax: A Case Report Cureus
Published: Jan. 20, 2025, 9:41 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Link copied to clipboard!